Who are Diethylcarbamazine on day 1's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/diethylcarbamazine-on-day-1.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Diethylcarbamazine on day 1 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diethylcarbamazine on day 1 (Diethylcarbamazine on day 1) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Microfilaricide. Area: Parasitic Infection / Tropical Medicine.

phase 3 Microfilaricide Microfilarial neuromuscular system Parasitic Infection / Tropical Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Diethylcarbamazine on day 1 (Diethylcarbamazine on day 1) — Lihir Medical Centre. Diethylcarbamazine immobilizes and kills microfilariae by interfering with their neuromuscular function, making them susceptible to immune clearance.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Diethylcarbamazine on day 1 TARGET	Diethylcarbamazine on day 1	Lihir Medical Centre	phase 3	Microfilaricide	Microfilarial neuromuscular system

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Microfilaricide class)

Lihir Medical Centre · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Diethylcarbamazine on day 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/diethylcarbamazine-on-day-1. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab